;PMID: 11410369
;source_file_2840.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..32] = [t:0..32]
;1)sentence:[e:38..123] = [t:38..123]
;2)section:[e:127..155] = [t:127..155]
;3)section:[e:159..305] = [t:159..305]
;4)sentence:[e:309..428] = [t:309..428]
;5)sentence:[e:429..581] = [t:429..581]
;6)sentence:[e:582..666] = [t:582..666]
;7)sentence:[e:667..793] = [t:667..793]
;8)sentence:[e:794..911] = [t:794..911]
;9)sentence:[e:912..979] = [t:912..979]
;10)sentence:[e:980..1075] = [t:980..1075]
;11)sentence:[e:1076..1129] = [t:1076..1129]
;12)sentence:[e:1130..1268] = [t:1130..1268]
;13)section:[e:1272..1317] = [t:1272..1317]

;section 0 Span:0..32
;Gene.  2001 Jun 13;271(1):87-92.
(SEC
  (FRAG (NNP:[0..4] Gene) (.:[4..5] .) (CD:[7..11] 2001) (NNP:[12..15] Jun)
        (CD:[16..22] 13;271) (-LRB-:[22..23] -LRB-) (CD:[23..24] 1)
        (-RRB-:[24..25] -RRB-) (::[25..26] :) (CD:[26..28] 87) (::[28..29] -)
        (CD:[29..31] 92) (.:[31..32] .)))

;sentence 1 Span:38..123
;Structure of the human M(2) muscarinic acetylcholine receptor gene and its 
;promoter.
;[61..99]:gene-rna:"M(2) muscarinic acetylcholine receptor"
(SENT
  (NP-HLN
    (NP (NN:[38..47] Structure))
    (PP (IN:[48..50] of)
      (NP
        (NP (DT:[51..54] the) (JJ:[55..60] human)
          (NML (NN:[61..65] M-LRB-2-RRB-) (JJ:[66..76] muscarinic)
               (NN:[77..90] acetylcholine) (NN:[91..99] receptor))
          (NN:[100..104] gene))
        (CC:[105..108] and)
        (NP (PRP$:[109..112] its) (NN:[114..122] promoter))))
    (.:[122..123] .)))

;section 2 Span:127..155
;Zhou C, Fryer AD, Jacoby DB.
(SEC
  (FRAG (NNP:[127..131] Zhou) (NNP:[132..133] C) (,:[133..134] ,)
        (NNP:[135..140] Fryer) (NNP:[141..143] AD) (,:[143..144] ,)
        (NNP:[145..151] Jacoby) (NNP:[152..155] DB.)))

;section 3 Span:159..305
;Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns 
;Hopkins University, 615 North Wolfe Street, Baltimore, MD 21205, USA.
(SEC
  (FRAG (NNP:[159..167] Division) (IN:[168..170] of) (NNP:[171..180] Pulmonary)
        (CC:[181..184] and) (NNP:[185..193] Critical) (NNP:[194..198] Care)
        (NNP:[199..207] Medicine) (,:[207..208] ,) (NNP:[209..215] School)
        (IN:[216..218] of) (NNP:[219..227] Medicine) (,:[227..228] ,)
        (NNP:[229..234] Johns) (NNP:[236..243] Hopkins)
        (NNP:[244..254] University) (,:[254..255] ,) (CD:[256..259] 615)
        (NNP:[260..265] North) (NNP:[266..271] Wolfe) (NNP:[272..278] Street)
        (,:[278..279] ,) (NNP:[280..289] Baltimore) (,:[289..290] ,)
        (NNP:[291..293] MD) (CD:[294..299] 21205) (,:[299..300] ,)
        (NNP:[301..304] USA) (.:[304..305] .)))

;sentence 4 Span:309..428
;The M(2) muscarinic receptor inhibits the release of acetylcholine from 
;cholinergic fibers in the lungs and elsewhere.
;[313..337]:gene-protein:"M(2) muscarinic receptor"
(SENT
  (S
    (NP-SBJ (DT:[309..312] The)
       (NN:[313..317] M-LRB-2-RRB-) (JJ:[318..328] muscarinic)
       (NN:[329..337] receptor))
    (VP (VBZ:[338..346] inhibits)
      (NP
        (NP (DT:[347..350] the) (NN:[351..358] release))
        (PP (IN:[359..361] of)
          (NP (NN:[362..375] acetylcholine)))
        (PP (IN:[376..380] from)
          (NP (JJ:[382..393] cholinergic) (NNS:[394..400] fibers))))
      (UCP-LOC
        (PP (IN:[401..403] in)
          (NP (DT:[404..407] the) (NNS:[408..413] lungs)))
        (CC:[414..417] and)
        (ADVP (RB:[418..427] elsewhere))))
    (.:[427..428] .)))

;sentence 5 Span:429..581
;In airway parasympathetic  neurons, M(2) receptor expression is decreased by
;viral infections and by  interferon-gamma, increasing actylcholine release.
;[465..478]:gene-generic:"M(2) receptor"
;[531..547]:gene-protein:"interferon-gamma"
(SENT
  (S
    (PP-LOC (IN:[429..431] In)
      (NP (NN:[432..438] airway) (JJ:[439..454] parasympathetic)
          (NNS:[456..463] neurons)))
    (,:[463..464] ,)
    (NP-SBJ-1
      (NML (NN:[465..469] M-LRB-2-RRB-) (NN:[470..478] receptor))
      (NN:[479..489] expression))
    (VP (VBZ:[490..492] is)
      (VP (VBN:[493..502] decreased)
        (NP-1 (-NONE-:[502..502] *))
        (PP
          (PP (IN:[503..505] by)
            (NP-LGS (JJ:[506..511] viral) (NNS:[512..522] infections)))
          (CC:[523..526] and)
          (PP (IN:[527..529] by)
            (NP-LGS (NN:[531..541] interferon) (HYPH:[541..542] -)
                    (SYM:[542..547] gamma))))
        (,:[547..548] ,)
        (S-ADV
          (NP-SBJ (-NONE-:[548..548] *))
          (VP (VBG:[549..559] increasing)
            (NP (NN:[560..572] actylcholine) (NN:[573..580] release))))))
    (.:[580..581] .)))

;sentence 6 Span:582..666
;Dexamethasone increases M(2)  receptor expression, decreasing acetylcholine
;release.
;[606..620]:gene-generic:"M(2)  receptor"
(SENT
  (S
    (NP-SBJ (NN:[582..595] Dexamethasone))
    (VP (VBZ:[596..605] increases)
      (NP
        (NML (NN:[606..610] M-LRB-2-RRB-) (NN:[612..620] receptor))
        (NN:[621..631] expression))
      (,:[631..632] ,)
      (S-ADV
        (NP-SBJ (-NONE-:[632..632] *))
        (VP (VBG:[633..643] decreasing)
          (NP (NN:[644..657] acetylcholine) (NN:[658..665] release)))))
    (.:[665..666] .)))

;sentence 7 Span:667..793
;We carried out 5' rapid  amplification of cDNA ends beginning with mRNA from
;human heart and IMR32 human  neuroblastoma cells.
;[773..786]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ (PRP:[667..669] We))
    (VP (VBD:[670..677] carried)
      (PRT (RP:[678..681] out))
      (NP
        (NP
          (NML (CD:[682..683] 5) (SYM:[683..684] '))
          (JJ:[685..690] rapid) (NN:[692..705] amplification))
        (PP (IN:[706..708] of)
          (NP (NN:[709..713] cDNA) (NNS:[714..718] ends))))
      (S-ADV
        (NP-SBJ (-NONE-:[718..718] *))
        (VP (VBG:[719..728] beginning)
          (PP (IN:[729..733] with)
            (NP
              (NP (NN:[734..738] mRNA))
              (PP (IN:[739..743] from)
                (NP
                  (NP (JJ:[744..749] human) (NN:[750..755] heart)
                    (NML-1 (-NONE-:[755..755] *P*)))
                  (CC:[756..759] and)
                  (NP (NN:[760..765] IMR32) (JJ:[766..771] human)
                      (NN:[773..786] neuroblastoma)
                    (NML-1 (NNS:[787..792] cells))))))))))
    (.:[792..793] .)))

;sentence 8 Span:794..911
;This demonstrated a 5' UTR of 100 BP, corresponding to two  sequences on
;chromosome 7, separated by a 22.6 kB intron.
(SENT
  (S
    (NP-SBJ (DT:[794..798] This))
    (VP (VBD:[799..811] demonstrated)
      (NP
        (NP
          (NP (DT:[812..813] a)
            (NML (CD:[814..815] 5) (SYM:[815..816] '))
            (NN:[817..820] UTR))
          (PP (IN:[821..823] of)
            (NP (CD:[824..827] 100) (NN:[828..830] BP))))
        (,:[830..831] ,)
        (VP (VBG:[832..845] corresponding)
          (PP-CLR (TO:[846..848] to)
            (NP
              (NP
                (NP (CD:[849..852] two) (NNS:[854..863] sequences))
                (PP-LOC (IN:[864..866] on)
                  (NP (NN:[867..877] chromosome) (CD:[878..879] 7))))
              (,:[879..880] ,)
              (VP (VBN:[881..890] separated)
                (NP (-NONE-:[890..890] *))
                (PP (IN:[891..893] by)
                  (NP-LGS (DT:[894..895] a)
                    (NML (CD:[896..900] 22.6) (NN:[901..903] kB))
                    (NN:[904..910] intron)))))))))
    (.:[910..911] .)))

;sentence 9 Span:912..979
;The splice acceptor  site is at -45 relative to the initiating atg.
(SENT
  (S
    (NP-SBJ (DT:[912..915] The)
      (NML (NN:[916..922] splice) (NN:[923..931] acceptor))
      (NN:[933..937] site))
    (VP (VBZ:[938..940] is)
      (PP-PRD (IN:[941..943] at)
        (NP (SYM:[944..945] -) (CD:[945..947] 45)))
      (S-ADV
        (NP-SBJ (-NONE-:[947..947] *))
        (ADJP-PRD (JJ:[948..956] relative)
          (PP (TO:[957..959] to)
            (NP (DT:[960..963] the) (VBG:[964..974] initiating)
                (NN:[975..978] atg))))))
    (.:[978..979] .)))

;sentence 10 Span:980..1075
;The 3000 BP upstream of 5' RACE  product were subcloned into a pGL3
;luciferase reporter vector.
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[980..983] The) (CD:[984..988] 3000) (NN:[989..991] BP))
      (ADJP (JJ:[992..1000] upstream)
        (PP (IN:[1001..1003] of)
          (NP
            (NML (CD:[1004..1005] 5) (SYM:[1005..1006] '))
            (NN:[1007..1011] RACE) (NN:[1013..1020] product)))))
    (VP (VBD:[1021..1025] were)
      (VP (VBN:[1026..1035] subcloned)
        (NP-1 (-NONE-:[1035..1035] *))
        (PP (IN:[1036..1040] into)
          (NP (DT:[1041..1042] a)
            (NML (NN:[1043..1047] pGL3) (NN:[1048..1058] luciferase))
            (NN:[1059..1067] reporter) (NN:[1068..1074] vector)))))
    (.:[1074..1075] .)))

;sentence 11 Span:1076..1129
;Deletional  constructs were expressed in IMR32 cells.
(SENT
  (S
    (NP-SBJ-1 (JJ:[1076..1086] Deletional) (NNS:[1088..1098] constructs))
    (VP (VBD:[1099..1103] were)
      (VP (VBN:[1104..1113] expressed)
        (NP-1 (-NONE-:[1113..1113] *))
        (PP-LOC (IN:[1114..1116] in)
          (NP (NN:[1117..1122] IMR32) (NNS:[1123..1128] cells)))))
    (.:[1128..1129] .)))

;sentence 12 Span:1130..1268
;These demonstrated that 412 BP  provided full expression of the reporter
;gene, and suggested a repressor element  between -1848 and -1510.
(SENT
  (S
    (NP-SBJ (DT:[1130..1135] These))
    (VP
      (VP (VBD:[1136..1148] demonstrated)
        (SBAR (IN:[1149..1153] that)
          (S
            (NP-SBJ (CD:[1154..1157] 412) (NN:[1158..1160] BP))
            (VP (VBD:[1162..1170] provided)
              (NP
                (NP (JJ:[1171..1175] full) (NN:[1176..1186] expression))
                (PP (IN:[1187..1189] of)
                  (NP (DT:[1190..1193] the) (NN:[1194..1202] reporter)
                      (NN:[1203..1207] gene))))))))
      (,:[1207..1208] ,) (CC:[1209..1212] and)
      (VP (VBD:[1213..1222] suggested)
        (NP
          (NP (DT:[1223..1224] a) (NN:[1225..1234] repressor)
              (NN:[1235..1242] element))
          (PP (IN:[1244..1251] between)
            (NP
              (NP (SYM:[1252..1253] -) (CD:[1253..1257] 1848))
              (CC:[1258..1261] and)
              (NP (SYM:[1262..1263] -) (CD:[1263..1267] 1510)))))))
    (.:[1267..1268] .)))

;section 13 Span:1272..1317
;PMID: 11410369 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1272..1276] PMID) (::[1276..1277] :) (CD:[1278..1286] 11410369)
        (NN:[1287..1288] -LSB-) (NNP:[1288..1294] PubMed) (::[1295..1296] -)
        (NN:[1297..1304] indexed) (IN:[1305..1308] for)
        (NNP:[1309..1317] MEDLINE-RSB-)))
